Experts condemn blanket ban on combination drugs at second edition of Vantage Point
Panelists highlight the need for proper guidelines and processes to weed out harmful FDCs from the market and ensure better safety…
Author
DRL launches nitroglycerin sublingual tablets in the US market
The Nitrostat (nitroglycerin) sublingual tablet brand had US sales of approximately $108 million MAT for the most recent twelve…
Shimadzu Corp launches new ICPMS 2030 in India
It is designed to help comply with USP 232/233 and ICH* Q3D guidelines for elemental impurities in pharma products
Shimadzu…
AstraZeneca updates on Phase III trial of Selumetinib in non-small cell lung cancer
Selumetinib did not meet trial endpoint of progression-free survival in KRASm NSCLC patients
AstraZeneca has announced results…
Morepen Labs announces financial results of Q1 2016-17
Company registered a 60 per cent increase in net profits for the first quarter
Morepen Laboratories has reported a 60 per cent…
GlaxoSmithKline Pharma declares Q1 financial performance
Net sales for the quarter came in at Rs 685 crores, recording a growth of eight per cent
GlaxoSmithKline Pharmaceuticals declared…
Almirall signs license agreement with Sun Pharma for Tildrakizumab in Europe for psoriasis
First IL-23p19 antibody to meet primary endpoints in pivotal phase-3 clinical trials in patients with moderate-to-severe plaque…
RPG Life Sciences to acquire seven prescription brands from Sun Pharma
It has also entered into collaboration with Biophore for the development of niche products for the US market
RPG Life Sciences has…
Price of older HIV drugs decreasing but salvage regimens 18 times more expensive than first line…
Trade agreements and pressure on India pose major threats to access
Doctors Without Borders/Médecins Sans Frontières (MSF)…
EMA accepts to review Mylan and Biocon’s regulatory submission for Pegfilgrastim
The proposed biosimilar is used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adult patients…